524 related articles for article (PubMed ID: 19660537)
1. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery.
Csaba N; Köping-Höggård M; Alonso MJ
Int J Pharm; 2009 Dec; 382(1-2):205-14. PubMed ID: 19660537
[TBL] [Abstract][Full Text] [Related]
2. Plasmid DNA-loaded chitosan/TPP nanoparticles for topical gene delivery.
Özbaş-Turan S; Akbuğa J
Drug Deliv; 2011 Apr; 18(3):215-22. PubMed ID: 21226549
[TBL] [Abstract][Full Text] [Related]
3. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.
Raja MA; Katas H; Jing Wen T
PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222
[TBL] [Abstract][Full Text] [Related]
4. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.
Hu B; Pan C; Sun Y; Hou Z; Ye H; Zeng X
J Agric Food Chem; 2008 Aug; 56(16):7451-8. PubMed ID: 18627163
[TBL] [Abstract][Full Text] [Related]
5. Receptor mediated gene delivery by folate conjugated N-trimethyl chitosan in vitro.
Zheng Y; Cai Z; Song X; Yu B; Bi Y; Chen Q; Zhao D; Xu J; Hou S
Int J Pharm; 2009 Dec; 382(1-2):262-9. PubMed ID: 19686829
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-g-PEG nanoparticles ionically crosslinked with poly(glutamic acid) and tripolyphosphate as protein delivery systems.
Papadimitriou SA; Achilias DS; Bikiaris DN
Int J Pharm; 2012 Jul; 430(1-2):318-27. PubMed ID: 22521711
[TBL] [Abstract][Full Text] [Related]
7. Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro.
Teijeiro-Osorio D; Remuñán-López C; Alonso MJ
Eur J Pharm Biopharm; 2009 Feb; 71(2):257-63. PubMed ID: 18955137
[TBL] [Abstract][Full Text] [Related]
8. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers.
Köping-Höggård M; Vårum KM; Issa M; Danielsen S; Christensen BE; Stokke BT; Artursson P
Gene Ther; 2004 Oct; 11(19):1441-52. PubMed ID: 15269712
[TBL] [Abstract][Full Text] [Related]
9. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
Gan Q; Wang T; Cochrane C; McCarron P
Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
[TBL] [Abstract][Full Text] [Related]
10. Formulation of chitosan-TPP-pDNA nanocapsules for gene therapy applications.
Gaspar VM; Sousa F; Queiroz JA; Correia IJ
Nanotechnology; 2011 Jan; 22(1):015101. PubMed ID: 21135452
[TBL] [Abstract][Full Text] [Related]
11. [Chitosan nanoparticles as gene vector: effect of particle size on transfection efficiency].
Yang XR; Zong L; Yuan XY
Yao Xue Xue Bao; 2007 Jul; 42(7):774-9. PubMed ID: 17882964
[TBL] [Abstract][Full Text] [Related]
12. A novel PEGylation of chitosan nanoparticles for gene delivery.
Zhang Y; Chen J; Zhang Y; Pan Y; Zhao J; Ren L; Liao M; Hu Z; Kong L; Wang J
Biotechnol Appl Biochem; 2007 Apr; 46(Pt 4):197-204. PubMed ID: 17147512
[TBL] [Abstract][Full Text] [Related]
13. Development and characterisation of chitosan nanoparticles for siRNA delivery.
Katas H; Alpar HO
J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo.
Köping-Höggård M; Mel'nikova YS; Vårum KM; Lindman B; Artursson P
J Gene Med; 2003 Feb; 5(2):130-41. PubMed ID: 12539151
[TBL] [Abstract][Full Text] [Related]
15. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
de la Fuente M; Seijo B; Alonso MJ
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2016-24. PubMed ID: 18436835
[TBL] [Abstract][Full Text] [Related]
16. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study.
Zheng F; Shi XW; Yang GF; Gong LL; Yuan HY; Cui YJ; Wang Y; Du YM; Li Y
Life Sci; 2007 Jan; 80(4):388-96. PubMed ID: 17074366
[TBL] [Abstract][Full Text] [Related]
17. The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine.
Zhou X; Zhang X; Yu X; Zha X; Fu Q; Liu B; Wang X; Chen Y; Chen Y; Shan Y; Jin Y; Wu Y; Liu J; Kong W; Shen J
Biomaterials; 2008 Jan; 29(1):111-7. PubMed ID: 17905427
[TBL] [Abstract][Full Text] [Related]
18. Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosan-TPP/nanoparticles formulated with IL-12.
Xu Q; Guo L; Gu X; Zhang B; Hu X; Zhang J; Chen J; Wang Y; Chen C; Gao B; Kuang Y; Wang S
Biomaterials; 2012 May; 33(15):3909-18. PubMed ID: 22374455
[TBL] [Abstract][Full Text] [Related]
19. Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector.
Gao S; Chen J; Dong L; Ding Z; Yang YH; Zhang J
Eur J Pharm Biopharm; 2005 Aug; 60(3):327-34. PubMed ID: 15894474
[TBL] [Abstract][Full Text] [Related]
20. Ionically crosslinked chitosan nanoparticles as gene delivery systems: effect of PEGylation degree on in vitro and in vivo gene transfer.
Csaba N; Köping-Höggård M; Fernandez-Megia E; Novoa-Carballal R; Riguera R; Alonso MJ
J Biomed Nanotechnol; 2009 Apr; 5(2):162-71. PubMed ID: 20055094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]